Epidemic of iron overload in dialysis population caused by intravenous iron products: A plea for moderation

American Journal of Medicine

Volumn 125, Issue 10, 2012, Pages 951-952

  Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; EDITORIAL; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; IRON OVERLOAD; KIDNEY FAILURE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REIMBURSEMENT;

ANEMIA; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; IRON OVERLOAD; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS;

EID: 84866478796     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.02.009     Document Type: Editorial

References (23)

1. N.D. Vaziri Oxidative stress in uremia: nature, mechanisms and potential consequences Semin Nephrol 24 2004 469 473
2. W.H. Hörl Clinical aspects of iron use in the anemia of kidney disease J Am Soc Nephrol 18 2007 382 393
3. C.S. Lim, N.D. Vaziri The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure Kidney Int 65 2004 1802 1809
4. A. Salahudeen, B. Oliver, J. Bower, J. Roberts Increase in plasma esterified F 2 isoprostanes following intravenous iron infusion in patients on hemodialysis Kidney Int 60 2001 1525 1531
5. D. Tovbin, D. Mazor, M. Vorobiov, C. Chaimovitz, N. Meyerstein Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation Am J Kidney Dis 40 2002 1005 1012
6. G. Guz, G.L. Glorieux, R. De Smet, M.A. Waterloos, R.C. Vanholder, A.W. Dhondt Impact of iron sucrose therapy on leukocyte surface molecules and reactive oxygen species in haemodialysis patients Nephrol Dial Transplant 21 2006 2834 2840
7. K. Kuo, S. Hung, Y. Wei, D. Tarng Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients J Am Soc Nephrol 19 2008 1817 1826
8. V.S. Kamanna, S.H. Ganji, S. Shelkovnikov, K. Norris, N.D. Vaziri Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration Am J Nephrol 35 2011 114 119
9. T. Drueke, Z. Massy, B. Descamps-Latscha Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease Circulation 106 2002 2212 2217
10. J.H. Pang, M.J. Jiang, Y.L. Chen Increased ferritin gene expression in atherosclerotic lesions J Clin Invest 97 1996 2204 2212
11. R. Deicher, F. Ziai, G. Cohen, M. Müllner, W.H. Hörl High dose parenteral iron sucrose depresses neutrophil intracellular killing capacity Kidney Int 64 2003 728 736
12. A. Gupta, J. Zhuo, J. Zha, S. Reddy, J. Olp, A. Pai Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival BMC Nephrol 11 2010 16
13. J.R. Boelaert, R.F. Daneels, E.G. Matthys, B.Z. Gordts, H.W. Van Landuyt Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study Nephrol Dial Transplant 5 1990 130 134
14. N.S. Green Yersinia infections in patients with homozygous beta thalassemia associated with iron overload and its treatment Pediatr Hematol Oncol 9 1992 247 254
15. B. Hoen, M. Kessler, D. Hestin, D. Mayeux Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey Nephrol Dial Transplant 10 1995 377 381
16. S. Swaminathan, V.A. Fonseca, M.G. Alam, S.V. Shah The role of iron in diabetes and its complications Diabetes Care 30 2007 1926 1933
17. KDOQI National Kidney Foundation ll. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults Am J Kidney Dis 47 2006 Sl6 S85
18. D.W. Coyne, T. Kapoian, W. Suki, A.K. Singh, J.E. Moran, N.V. Dahl DRIVE Study Group Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study J Am Soc Nephrol 18 2007 975 984
19. G. Rostoker, M. Griuncelli, C. Loridon Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: A MRI study Am J Med 125 2012 991 999
20. C. Canavese, D. Bergamo, G. Ciccone Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients Kidney Int 65 2004 1091 1098
21. P. Ferrari, H. Kulkarni, C. Harrison, T.G. St Pierre, J.K. Olynyk Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease Clin J Am Soc Nephrol 6 2011 77 83
22. T. Nakanishi, Y. Hasuike, Y. Otaki, A. Kida, H. Nonoguchi, T. Kuragano Hepcidin: another culprit for complications in patients with chronic kidney disease? Nephrol Dial Transplant 26 2011 3092 3100
23. R.E. Fleming, R.S. Britton, A. Waheed, W.S. Sly, B.R. Bacon Pathophysiology of hereditary hemochromatosis Semin Liver Dis 2 2005 411 419